GlassScriptPhysician profile
Lee B Sigmon
NPI 1750609178
$9,262.76
in general payments reported to CMS, 2019-2025
9 companies · $8,600 in 2025
The $8,600 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2022: $409 · 2023: $102 · 2024: $30.46 · 2025: $8,600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,440 · Food and Beverage: $827 · Consulting Fee: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,440.00 |
| Food and Beverage | $827.45 |
| Consulting Fee | $465.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wilson Cook Medical Incorporated | $7,440.00 | 2025 | |
| Cook Medical LLC | $541.12 | 2024-2025 | Hemospray |
| Cook Incorporated | $465.00 | 2025 | Hemospray |
| Medtronic, INC. | $409.23 | 2022 | |
| Abbvie INC. | $189.79 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $102.29 | 2023 | Rebyota |
| Janssen Biotech, INC. | $40.29 | 2025 | Tremfya |
| Pentax of America, INC. | $39.92 | 2025 | Pentax Medical, C2 Cryoballoon, Inspira |
| Boston Scientific Corporation | $35.12 | 2025 | General - Enteral Feeding |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Sigmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.